# Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy

> **NCT04810910** · PHASE1 · UNKNOWN · sponsor: **Zhejiang Provincial People's Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Resectable Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** iNeo-Vac-P01
- **OTHER:** GM-CSF

## Key facts

- **NCT ID:** NCT04810910
- **Lead sponsor:** Zhejiang Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-30
- **Primary completion:** 2025-03-30
- **Final completion:** 2025-03-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04810910

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04810910, "Personalized Neoantigen Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04810910. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*